Production (Stage)
Astrana Health, Inc.
ASTH
$24.29
-$0.18-0.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.31M | 5.55M | 2.75M | 1.60M | 4.08M |
| Total Other Revenue | 618.08M | 659.66M | 475.96M | 484.66M | 400.28M |
| Total Revenue | 620.39M | 665.21M | 478.71M | 486.27M | 404.36M |
| Cost of Revenue | 549.06M | 614.73M | 405.22M | 412.81M | 330.40M |
| Gross Profit | 71.33M | 50.48M | 73.49M | 73.46M | 73.96M |
| SG&A Expenses | 43.90M | 41.63M | 37.80M | 35.95M | 38.72M |
| Depreciation & Amortization | 6.85M | 8.13M | 7.26M | 7.44M | 5.10M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 599.81M | 664.49M | 450.29M | 456.20M | 374.22M |
| Operating Income | 20.58M | 720.00K | 28.43M | 30.07M | 30.14M |
| Income Before Tax | 9.60M | -1.90M | 26.81M | 31.90M | 24.00M |
| Income Tax Expenses | 3.38M | 5.88M | 7.83M | 10.03M | 7.14M |
| Earnings from Continuing Operations | 6.22M | -7.78M | 18.98M | 21.87M | 16.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 471.00K | 826.00K | -2.89M | -2.70M | -2.03M |
| Net Income | 6.69M | -6.95M | 16.09M | 19.17M | 14.84M |
| EBIT | 20.58M | 720.00K | 28.43M | 30.07M | 30.14M |
| EBITDA | 27.43M | 8.85M | 35.69M | 37.51M | 35.24M |
| EPS Basic | 0.14 | -0.15 | 0.34 | 0.40 | 0.31 |
| Normalized Basic EPS | 0.13 | 0.01 | 0.27 | 0.36 | 0.26 |
| EPS Diluted | 0.14 | -0.15 | 0.33 | 0.40 | 0.31 |
| Normalized Diluted EPS | 0.13 | 0.01 | 0.27 | 0.36 | 0.26 |
| Average Basic Shares Outstanding | 48.47M | 46.34M | 47.69M | 47.62M | 47.26M |
| Average Diluted Shares Outstanding | 48.85M | 46.34M | 48.22M | 47.98M | 47.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 81.52% | -- | -- | -- | -- |